(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
Cogent Biosciences, Inc.
Cogent Biosciences, Inc.
Pfizer
Sixth Affiliated Hospital, Sun Yat-sen University
National University of Malaysia
Blueprint Medicines Corporation
Trinity Health Michigan
Eli Lilly and Company
Mount Carmel Health System
Yonsei University
Cantonal Hospital of St. Gallen
Cheju Halla General Hospital